These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 30677766

  • 1. Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia.
    Ilyina NI, Edin AS, Astafieva NG, Lopatin AS, Sidorenko IV, Ukhanova OP, Khanova FM.
    Int Arch Allergy Immunol; 2019; 178(3):255-263. PubMed ID: 30677766
    [Abstract] [Full Text] [Related]

  • 2. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
    Carr WW, Ratner P, Munzel U, Murray R, Price D, Canonica GW, Mullol J, Virchow JC, Lieberman P, Meltzer E, Bachert C.
    Allergy Asthma Proc; 2012; 33(6):450-8. PubMed ID: 23127291
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment.
    Berger W, Meltzer EO, Amar N, Fox AT, Just J, Muraro A, Nieto A, Valovirta E, Wickman M, Bousquet J.
    Pediatr Allergy Immunol; 2016 Mar; 27(2):126-33. PubMed ID: 26928753
    [Abstract] [Full Text] [Related]

  • 4. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.
    Meltzer EO, LaForce C, Ratner P, Price D, Ginsberg D, Carr W.
    Allergy Asthma Proc; 2012 Mar; 33(4):324-32. PubMed ID: 22856633
    [Abstract] [Full Text] [Related]

  • 5. Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK.
    Scadding G, Price D, El-Shanawany T, Ahmed S, Ray J, Sargur R, Kumar N.
    BMJ Open; 2017 Apr 24; 7(4):e014777. PubMed ID: 28442578
    [No Abstract] [Full Text] [Related]

  • 6. Intranasal spray medications for maintenance therapy of allergic rhinitis.
    Berger WE, Meltzer EO.
    Am J Rhinol Allergy; 2015 Apr 24; 29(4):273-82. PubMed ID: 26132312
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Real-life effectiveness of MP-AzeFlu in Irish patients with persistent allergic rhinitis, assessed by visual analogue scale and endoscopy.
    Kaulsay R, Nguyen DT, Kuhl HC.
    Immun Inflamm Dis; 2018 Dec 24; 6(4):456-464. PubMed ID: 30306729
    [Abstract] [Full Text] [Related]

  • 10. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
    Ratner PH, Hampel F, Van Bavel J, Amar NJ, Daftary P, Wheeler W, Sacks H.
    Ann Allergy Asthma Immunol; 2008 Jan 24; 100(1):74-81. PubMed ID: 18254486
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J, Storms W, Bernstein J, Berger W, Nayak A, Sacks H, Azelastine Cetirizine Trial No. 1 (ACT 1) Study Group.
    Clin Ther; 2005 May 24; 27(5):543-53. PubMed ID: 15978303
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the US.
    Prenner BM.
    J Asthma Allergy; 2016 May 24; 9():135-43. PubMed ID: 27468241
    [Abstract] [Full Text] [Related]

  • 14. Deposition characteristics of a novel intranasal formulation of azelastine hydrochloride plus fluticasone propionate in an anatomic model of the human nasal cavity.
    Meltzer EO, Bachert C, Mayer MJ, Kopietz F, Koltun A, Maus J, D'Addio AD.
    Allergy Asthma Proc; 2020 Jul 01; 41(4):265-270. PubMed ID: 32393418
    [Abstract] [Full Text] [Related]

  • 15. MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review.
    Klimek L, Berger WE, Bousquet J, Keith PK, Smith P, Sole D, Scadding G, Kuhl HC, Nguyen DT, Kopietz F, Koltun A.
    Int Arch Allergy Immunol; 2021 Jul 01; 182(11):1026-1035. PubMed ID: 34082425
    [Abstract] [Full Text] [Related]

  • 16. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
    Shah SR, Nayak A, Ratner P, Roland P, Michael Wall G.
    Clin Ther; 2009 Jan 01; 31(1):99-107. PubMed ID: 19243710
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis.
    Berger W, Hampel F, Bernstein J, Shah S, Sacks H, Meltzer EO.
    Ann Allergy Asthma Immunol; 2006 Sep 01; 97(3):375-81. PubMed ID: 17042145
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis.
    Meltzer E, Ratner P, Bachert C, Carr W, Berger W, Canonica GW, Hadley J, Lieberman P, Hampel FC, Mullol J, Munzel U, Price D, Scadding G, Virchow JC, Wahn U, Murray R, Bousquet J.
    Int Arch Allergy Immunol; 2013 Sep 01; 161(4):369-77. PubMed ID: 23652808
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.